UnknownNot Applicable

Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm

China800 participantsStarted 2023-05-01

Plain-language summary

This study aims to quantify the malignant potential of non-functional neuroendocrine tumors of the pancreatic body and tail ≤ 3 cm by collecting real-world data from large pancreatic centers across the country, and to evaluate the appropriateness of parenchyma-sparing resection and oncologic resection.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non-functional neuroendocrine tumors of the pancreatic body and tail ≤ 3 cm. Exclusion Criteria: * Presence of liver or distant metastasis. * Presence of concomitant malignancy. * Multifocal or recurrent disease. * Presence of hereditary syndrome (MEN1, VHL, NF). * Presence of symptoms (specific symptoms of clinical syndromes suspected to be related to excessive secretion of bioactive compounds). * History of preoperative antitumor therapy. * Loss to follow-up.

What they're measuring

Overall survival (OS)

Timeframe: Through study completion, an average of 1 year.

Disease-free survival (DFS)

Timeframe: Through study completion, an average of 1 year.

Trial details

NCT IDNCT05907824

SponsorFudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

Contact for this trial

Xianjun Yu, MD, PhD

+86-13801669875 yuxianjun@fudanpci.org

View on ClinicalTrials.gov More Non Functioning Pancreatic Endocrine Tumor trials